Through strategic guidance, visionary thinking, and a relentless pursuit of excellence, our senior executives steer SPT Labtech towards achieving its mission of making a real difference to human health through solving advanced laboratory challenges.
Learn more
Board of Directors
Our Board of Directors are committed to driving the long-term success and sustainability of SPT Labtech, providing expert guidance and oversight to execute the company’s ambitious commercial strategy.
Learn more
10
SPT Labtech and Alithea Genomics Collaborate to Automate Ultra Sensitive Single-Cell Transcriptomic Workflows
Continue reading
SPT Labtech and 10x Genomics Partner to Automate Single Cell Workflows
Continue reading
SPT Labtech and Agilent Introduce Automated Target Enrichment Protocols for Genomic Workflows
Continue reading
TTP LabTech has today released the results of a valuable benchmarking study using its mirrorball® antibody discovery system. The data accurately demonstrates that mirrorball offers equivalent data to the discontinued ABI 8200 FMAT® instrument, with minimal changes to assay protocols.
Mix-and-read assays, first popularized as FMAT assays, were developed to overcome the problems associated with automating ELISAs particularly in cell-based methods. This new comparative study has used the FMAT assay to look at bead-based quantitation of a soluble protein (rabbit IgG) and antibody binding to EGF receptors expressed in A459 cells. The mirrorball system scanned the entire well, and FMAT reported data from only a 1 mm2 area in each well. Beads were identified by laser scatter on mirrorball and fluorescence on FMAT. The mirrorball system could enumerate beads in all wells, in contrast to FMAT which could not detect all beads below 1 ng/mL rabbit IgG.
The study demonstrated that the performance of both systems was broadly similar, with sensitivity estimated at about 5 ng/mL antibody.